Serum antibodies in Campylobacter enteritis.

Area of Science:

• Immunology
• Microbiology
• Clinical Diagnostics

Background:

• Campylobacter jejuni is a leading cause of bacterial gastroenteritis worldwide.
• Accurate serological methods are crucial for diagnosing C. jejuni infections and understanding host immune responses.
• Previous diagnostic methods may lack sensitivity or specificity for detecting specific antibody classes.

Purpose of the Study:

• To develop and validate a sensitive and specific solid-phase enzyme immunoassay (EIA) for measuring total and class-specific serum antibodies to Campylobacter jejuni.
• To evaluate the diagnostic utility of this EIA in patients with Campylobacter enteritis.
• To analyze the patterns of immunoglobulin M, G, and A antibody responses in relation to disease course.

Main Methods:

• Development of a solid-phase enzyme immunoassay (EIA) technique.
• Measurement of total and class-specific (IgM, IgG, IgA) serum antibodies against C. jejuni.
• Analysis of antibody levels in sera from patients recovering from Campylobacter enteritis.

Main Results:

• The developed EIA demonstrated high sensitivity and specificity for detecting C. jejuni antibodies.
• Approximately 90% of recovering patients showed detectable IgM, IgG, and IgA antibodies.
• Antibody profiles correlated with typical acute infection patterns, while intermittent/prolonged enteritis showed a weaker response.

Conclusions:

• The developed solid-phase EIA is a valuable tool for diagnosing Campylobacter enteritis.
• The assay provides insights into the dynamics of specific antibody responses during C. jejuni infection.
• Understanding antibody patterns can help differentiate infection types and assess clinical outcomes.